3D Cardiac Mapping Systems Market Growth, Size, Trends, Analysis Report by Type, Application, Region and Segment Forecast 2022-2026

The 3D cardiac mapping systems market share is expected to increase by USD 444.5 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 8.36%.

This 3D cardiac mapping systems market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers 3D cardiac mapping systems market segmentation by product (contact 3D cardiac mapping systems and non-contact 3D cardiac mapping systems) and geography (North America, Europe, Asia, and Rest of World (ROW)). The 3D cardiac mapping systems market report also offers information on several market vendors, including Abbott Laboratories, Acutus Medical Inc., APN Health LLC, BioSig Technologies Inc., BIOTRONIK SE and Co KG, Boston Scientific Corp., Catheter Precision Inc., CoreMap Inc., EPMap-System GmbH, Johnson and Johnson, Koninklijke Philips NV, Medtronic Plc, MicroPort Scientific Corp., Kardium Inc., and Sichuan Jinjiang Electronic Science and Technology Co. Ltd. among others.

What will the 3D Cardiac Mapping Systems Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the 3D Cardiac Mapping Systems Market Size for the Forecast Period and Other Important Statistics

 

3D Cardiac Mapping Systems Market: Key Drivers, Trends, and Challenges

The rising incidence of cardiac diseases and growth of insurance providers is notably driving the 3D cardiac mapping systems market growth, although factors such as lack of trained electrophysiologists and cardiologist surgeons may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the 3D cardiac mapping systems industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key 3D Cardiac Mapping Systems Market Driver

One of the key factors driving growth in the 3D cardiac mapping systems market is the rising incidence of cardiac diseases and growth of insurance providers. The incidence of heart diseases is increasing in developed as well as developing countries. The prevalence of heart valve diseases is also rising due to the increased life expectancy in the elderly population. Heart valve disease is one of the most serious and common valve diseases and is likely to increase with advancing age. Thus, the growing prevalence of heart valve diseases, such as CHD, aortic stenosis, and mitral heart valve diseases, is likely to increase the demand for heart disease treatment devices, including 3D cardiac mapping systems, and drive market growth. With the increasing number of hypertension cases globally, the number of Medicare providers such as hospitals and clinics is growing. The rise in the number of cardiac disease cases increases the volume of treatment procedures that include disease diagnosis and cardiac surgeries. This increases the number of cardiac ablation procedures, which increases the demand, sales, and use of 3D cardiac mapping systems in the market.

Key 3D Cardiac Mapping Systems Market Trend

The growing number of strategic alliances is a 3D cardiac mapping systems market trend that is expected to have a positive impact in the coming years. Strategic alliances can help medical equipment vendors explore additional opportunities without incurring a considerable financial burden. Such alliances for product development and product commercialization provide vendors with multiple benefits such as cost containment, extended product line, and increased geographical reach. All these factors accelerate the growth of the healthcare equipment market, including the global 3D cardiac mapping systems market. The increasing number of partnerships and collaborations between vendors, end-users, and government organizations will expand vendor's global presence and contribute to market growth during the forecast period.

Key 3D Cardiac Mapping Systems Market Challenge

The lack of trained electrophysiologists and cardiologist surgeons will be a major challenge for the 3D cardiac mapping systems market during the forecast period. The reasons for this declining interest appear to be multiple. The number of coronary artery bypass grafting (CABG) operations, a mainstay of the specialty, decreased by 28% between 2015 and 2020, whereas the number of claims for cardiac stent placement, a procedure performed by cardiologists and not cardiac surgeons, increased by 121%. Students are not opting for cardiology specialty, and medical seats are not getting filled. The steady drop in CABG rates since 2017 has been accompanied by a 38% decline in Medicare reimbursement for the operation and an increase in the difficulty that the recent graduates of cardiothoracic surgical programs have encountered in finding jobs after their training. Concerned by the falling number of cardiothoracic surgery trainees and the impact on care for a growing patient population with cardiovascular disease, the American Association for Thoracic Surgery, with the support of the Society of Thoracic Surgeons, commissioned the Association of American Medical Colleges Center for Workforce Studies to undertake a comprehensive study of the supply of cardiothoracic surgeons and the demand for their services through 2025. Thus, it can be a major challenge for cardiac patients during the forecast period.

This 3D cardiac mapping systems market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global 3D cardiac mapping systems market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the 3D cardiac mapping systems market during the forecast period.

Who are the Major 3D Cardiac Mapping Systems Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Abbott Laboratories
• Acutus Medical Inc.
• APN Health LLC
• BioSig Technologies Inc.
• BIOTRONIK SE and Co KG
• Boston Scientific Corp.
• Catheter Precision Inc.
• CoreMap Inc.
• EPMap-System GmbH
• Johnson and Johnson
• Koninklijke Philips NV
• Medtronic Plc
• MicroPort Scientific Corp.
• Kardium Inc.
• Sichuan Jinjiang Electronic Science and Technology Co. Ltd.

 

This statistical study of the 3D cardiac mapping systems market encompasses successful business strategies deployed by the key vendors. The 3D cardiac mapping systems market is concentrated and the vendors are deploying growth strategies such as focusing on acquiring other small brands to increase their market presence to compete in the market.

Product Insights and News

• abbott.com - Under the established pharmaceuticals products segment, the company manufacturers branded generic pharmaceuticals for established and emerging markets.

• abbott.com - The company offers 3D cardiac mapping systems such as EnSite X EP System.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The 3D cardiac mapping systems market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

3D Cardiac Mapping Systems Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the 3D cardiac mapping systems market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for 3D Cardiac Mapping Systems Market?

For more insights on the market share of various regions Request for a FREE sample now!

44% of the market's growth will originate from North America during the forecast period. The US is the key market for 3D cardiac mapping systems in North America. Market growth in this region will be faster than the growth of the market in other regions.

The high prevalence of cardiac arrhythmias will facilitate the 3D cardiac mapping systems market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 adversely affected all countries in North America, especially the US, in 2020. However, it had only a slightly negative impact on the 3D cardiac mapping systems market in the region. However, by the second half of 2020, lockdown-related restrictions were somewhat relaxed in various countries, which allowed the movement of people outside their homes. Thus, the market is expected to grow during the forecast period as postponed surgeries are performed. Owing to these factors, the regional market will register growth during the forecast period.

What are the Revenue-generating Product Segments in the 3D Cardiac Mapping Systems Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The 3D cardiac mapping systems market share growth by the contact 3D cardiac mapping systems segment will be significant during the forecast period. Technological advances of these systems offer well-established magnetic and impedance mapping, high-density mapping with enhanced accuracy, and simultaneous recording of a large number of electrograms (EGMs) with a very high spatial resolution. Hence, the demand for these systems is expected to drive market growth during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the 3D cardiac mapping systems market size and actionable market insights on post COVID-19 impact on each segment.

 

3D Cardiac Mapping Systems Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 8.36%
Market growth 2022-2026	$ 444.5 million
Market structure	Concentrated
YoY growth (%)	7.98
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 44%
Key consumer countries	US, Germany, UK, China, and Japan
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Abbott Laboratories, Acutus Medical Inc., APN Health LLC, BioSig Technologies Inc., BIOTRONIK SE and Co KG, Boston Scientific Corp., Catheter Precision Inc., CoreMap Inc., EPMap-System GmbH, Johnson and Johnson, Koninklijke Philips NV, Medtronic Plc, MicroPort Scientific Corp., Kardium Inc., and Sichuan Jinjiang Electronic Science and Technology Co. Ltd.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this 3D Cardiac Mapping Systems Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive 3D cardiac mapping systems market growth during the next five years
• Precise estimation of the 3D cardiac mapping systems market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the 3D cardiac mapping systems industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of 3D cardiac mapping systems market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch